Michael Rapp is Director at Immunome Inc. (IMNM). They have made 11 open-market trades across 3 companies since 2013, most recently 2023-10-02.
CIK 0001405685
11 open-market purchases totalling $8.5M since 2013, never a sale. Across 10 scored buys the stock is down 13.0% at ninety days, and 18.4 points behind the S&P over the same stretch.
10 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 50% | 40% | 30% |
| Avg Move | +2.1% | -3.2% | -13.0% |
| Alpha | +1.1% | -4.3% | -18.4% |
| Scored | 10 | 10 | 10 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| IMNM | BUY | 2021-09-13 | 2021-09-14 | $19.96 | $1.0M | +26.5% | -19.2% | -23.7% |
| IMNM | BUY | 2021-09-09 | 2021-09-13 | $18.12 | $1.4M | +23.2% | -16.7% | -20.3% |
| IMNM | BUY | 2021-05-24 | 2021-05-26 | $18.37 | $1.9M | -12.2% | -14.2% | -33.5% |
| IMNM | BUY | 2020-10-06 | 2020-10-08 | $12.00 | $1000K | -12.8% | -20.8% | -33.6% |
| ZYNE | BUY | 2018-05-30 | 2018-05-31 | $10.45 | $123K | +5.4% | -9.7% | -25.5% |
| ZYNE | BUY | 2018-05-02 | 2018-05-02 | $10.46 | $157K | -9.1% | +5.2% | -35.9% |
| ZYNE | BUY | 2018-03-22 | 2018-03-23 | $9.28 | $93K | +1.4% | +15.1% | +37.7% |
| ZYNE | BUY | 2018-01-02 | 2018-01-03 | $12.99 | $195K | -17.1% | -19.5% | -32.9% |
| ZYNE | BUY | 2017-10-19 | 2017-10-23 | $9.73 | $1.7M | -5.0% | +40.7% | +11.5% |
| ZYNE | BUY | 2016-12-29 | 2016-12-29 | $15.85 | $159K | +20.2% | +7.0% | +25.9% |
| CCAC | BUY | 2013-10-16 | 2013-10-18 | $5.00 | $815K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.